ASX Press Release: June 13, 2017

Boardroom Media Interview: Positive Full Year Results Expected

ITL Health Group is pleased to provide the opportunity to listen to an audio interview with Mr. Bill Mobbs, Executive Chairman.

Mr. Mobbs talks about the Trading Update issued today which states that ITL expects to announce very positive results for the financial year to 30^th June 2017.

Click here for the Boardroom Media interview:

https://boardroom.media/broadcast/preview/?refid=&eid=593f7f256f8db701be9db376

Read original article →

ITL BioMedical enables best clinical outcomes through innovative tools for blood management and clinical procedures. As a global provider of blood management and clinical procedure tools with a significant portfolio of intellectual property, we consistently look to the future and leverage input from healthcare markets worldwide to advance our products. Our world-class manufacturing facility and R&D lab develops and rigorously tests our advancements ensuring our innovations are designed with the utmost quality for introduction on a global basis.

Boardroom Media Interview: Positive Full Year Results Expected

Essentials for Blood Management and Clinical Procedures

Product Catalogue